Background and objective: Treatment of certain dermal filler–related serious AEs (e.g., vascular occlusion, granulomatous reactions) may include removal of the injected material. Hyaluronidase can be used to degrade hyaluronic acid fillers; however, no agents have yet been shown to fully dissolve calcium hydroxylapatite (CaHA; Merz North America) filler after placement. Sodium thiosulfate (STS) has been shown to decrease calcium mineral deposits associated with calciphylaxis, calcific uremic arteriolopathy, and kidney stones.
Δευτέρα 13 Αυγούστου 2018
Sodium thiosulfate injection dissolves calcium hydroxylapatite particles: An animal study
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
-
Small molecule inhibitor of the Wnt pathway (SM04755) as a potential topical treatment for psoriasisBackground: Psoriasis (PSO) is an autoimmune disease causing patches of thick, inflamed, scaly skin due to excessive proliferation of skin c...
-
Clinical and animal studies show that ethanol exposure and inflammation during pregnancy cause similar behavioral disturbances in the offspr...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Σημείωση: Μόνο ένα μέλος αυτού του ιστολογίου μπορεί να αναρτήσει σχόλιο.